002172 澳洋健康
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)20.99535.51871.964-28.627-204.613
总资产报酬率 ROA (%)1.5701.8902.008-0.471-20.272
投入资产回报率 ROIC (%)2.2032.6872.754-0.681-28.046

边际利润分析
销售毛利率 (%)14.84513.38613.48513.9407.517
营业利润率 (%)5.2053.3643.7720.412-36.105
息税前利润/营业总收入 (%)7.2494.8174.7313.166-31.024
净利润/营业总收入 (%)3.5432.0522.312-0.778-35.234

收益指标分析
经营活动净收益/利润总额(%)102.72491.05979.409-519.66629.931
价值变动净收益/利润总额(%)-0.746-2.01429.6901,647.5440.369
营业外收支净额/利润总额(%)-0.108-3.732-17.216963.344-1.386

偿债能力分析
流动比率 (X)0.6400.6540.6450.7230.804
速动比率 (X)0.5580.5670.5550.6530.757
资产负债率 (%)92.57894.38296.66299.01098.670
带息债务/全部投入资本 (%)82.24082.61593.11293.65189.734
股东权益/带息债务 (%)14.13011.3456.3662.3312.828
股东权益/负债合计 (%)9.1156.9494.3331.6481.674
利息保障倍数 (X)3.5363.0603.1260.985-6.763

营运能力分析
应收账款周转天数 (天)61.62252.20150.157135.98691.839
存货周转天数 (天)33.18634.42334.36735.20727.735